Possible involvement of GLP‐1(9–36) in the regional haemodynamic effects of GLP‐1(7–36) in conscious rats
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE The incretin hormone, glucagon‐like peptide (GLP)‐1(7–36), is rapidly cleaved by dipeptidyl peptidase 4 (DPP‐4) into GLP‐1(9–36), and although it is agreed that most, if not all, of the metabolic effects are attributable to the intact peptide, the degree to which the cardiovascular effects are due to the cleavage product is unclear. The purpose of this study was to measure the regional haemodynamic effects of GLP‐1(7–36), and determine the extent to which the cardiovascular effects of GLP‐1(7–36) were influenced by DPP‐4 inhibition and reproduced by GLP‐1(9–36). Additional experiments investigated the involvement of autonomic mechanisms in the cardiovascular effects of GLP‐1(7–36). EXPERIMENTAL APPROACH Regional haemodynamic effects of bolus doses and 4 h infusions of GLP‐1(7–36) amide and GLP‐1(9–36) amide were measured in conscious, chronically instrumented rats; the influence of DPP‐4 inhibition and autonomic blockade on responses to GLP‐1(7–36) were also assessed. KEY RESULTS Glucagon‐like peptide‐1(7–36) had clear regional haemodynamic effects comprising tachycardia, a rise in blood pressure, renal and mesenteric vasoconstriction and hindquarters vasodilatation, whereas GLP‐1(9–36) was devoid of any cardiovascular actions. The effects of GLP‐1(7–36) were enhanced by DPP‐4 inhibition, and the tachycardia and hindquarters vasodilatation were β‐adrenoceptor‐mediated. CONCLUSIONS AND IMPLICATIONS In conscious rats, the cardiovascular effects of GLP‐1(7–36) resemble those of the GLP analogue, exendin‐4, and are attributable to the intact peptide rather than the cleavage product, GLP‐1(9–36).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057 · cited 4×
“In contrast, others have reported distinct cardiovascular effects of GLP-1(7–36) and GLP-1(9–36), the former, but not the latter being GLP-1 receptor-dependent (Ban et al., 2008; Ossum et al., 2009).”
BackgroundInfluentialDeacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792 · cited 1×
“Release of GLP-1(7–36) in response to feeding is extremely rapid, but circulating levels then quickly fall (halflife 1–2 min), mainly due to enzymatic cleavage of the two N-terminal amino acids by dipeptidyl peptidase 4 (DPP-4), to form GLP-1(9–36) (Deacon et al., 1995).”
BackgroundYamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429
Nikolaidis, L. A., Elahi, D., Shen, Y.-T., & Shannon, R. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00347.2005 · Cited by 274 · cited 4×
“Alternatively, or additionally, species differences could explain the apparent disparity between our findings in rats, and those of Nikolaidis et al. (2005) in dogs.”
BackgroundResultInfluentialBarragán, J. M., Eng, J., Rodríguez, R., & Blázquez, E. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e784 · Cited by 142 · cited 2×
“This is not the first study to describe pressor and tachycardic effects of systemic administration of bolus doses of GLP-1(7–36) in rats (Barragán et al., 1994; 1996; 1999; Bojanowska and Stempniak, 2002; Yamamoto et al., 2002), but to our knowledge it is the first to describe the associated…”
BackgroundMeier, J. J., Gethmann, A., Nauck, M. A., Götze, O., Schmitz, F., Deacon, C. F., Gallwitz, B., Schmidt, W. E., & Holst, J. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00576.2005 · Cited by 104 · cited 1×
“However, GLP1(9–36) may not be completely devoid of glucoregulatory actions inasmuch as some investigators (Deacon et al., 2002, Meier et al., 2006), but not others (Vahl et al., 2003) have demonstrated a glucose-lowering effect of the peptide that was independent of insulin secretion.”
Background
Cited by
Richards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., & Reimann, F. (2014) · Diabetes · doi:10.2337/db13-1440 · Cited by 472
“The underlying physiology appears complex, however, and in rats, GLP-1 was found to act as a vasodilator in the periphery but as a vasoconstrictor in the splanchnic bed (20).”
BackgroundJensen, E. P., Poulsen, S. S., Kissow, H., Holstein-Rathlou, N.-H., Deacon, C. F., Jensen, B. L., Holst, J. J., & Sorensen, C. M. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00527.2014 · Cited by 141
Tesauro, M., Schinzari, F., Adamo, A., Rovella, V., Martini, F., Mores, N., Barini, A., Pitocco, D., Ghirlanda, G., Lauro, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0763 · Cited by 54
Forst, T., Weber, M. M., & Pfützner, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/635472 · Cited by 44
Tate, M., Chong, A., Robinson, E., Green, B. D., & Grieve, D. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12943 · Cited by 33
Metadata
- Authors
- Gardiner, S., March, J., Kemp, P., Bennett, T., & Baker, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-08-18
- Volume
- 161
- Issue
- 1
- Pages
- 92-102
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1605414982
- Cited by
- 28
- References
- 6
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Possible involvement of GLP‐1(9–36) in the regional haemodynamic effects of GLP‐1(7–36) in conscious rats. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.00867.x
- The paper
- Gardiner, S., March, J., Kemp, P., Bennett, T., & Baker, D. (2010). Possible involvement of GLP‐1(9–36) in the regional haemodynamic effects of GLP‐1(7–36) in conscious rats. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00867.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.